News Research news

2026: reflecting on the last year’s research progress and looking at what’s ahead

2025 was one of our most exciting years yet for Parkinson’s research. We saw the launch of EJS ACT-PD, the world’s largest clinical trial for Parkinson’s, the start of recruitment for the phase 3 trial of ambroxol, the forging of new strategic partnerships, and much…


News Press release

Cure Parkinsons and Van Andel Institute renew funding for Parkinson’s clinical trial programme  

Cure Parkinson’s and Van Andel Institute (VAI) have renewed a funding agreement to support the International Linked Clinical Trials (iLCT) programme, the world’s largest drug repurposing clinical trial initiative for Parkinson’s disease.    As part of the three-year agreement, VAI and Cure Parkinson’s each pledge $750,000…


Get your paws on a #SophieFromRomania 2026 calendar this Christmas!

For the second year in a row, we’ve collaborated with our patron Rory Cellan-Jones to create a stunning 2026 calendar, featuring his beloved rescue dog Sophie! We’re pleased to be once again selling a Sophie from Romania calendar, after the success of last year’s edition!…


Read the Autumn/Winter 2025 edition of Cure InSight

A new edition of Cure InSight, our twice yearly newsletter that showcases our research and fundraising activities, has been published. Each edition contains landmark moments of our research to find a cure, individuals making outstanding contributions to our work, and the many ways our supporters…


News Press release

Launch of a Global Alliance for Parkinson’s Platforms (GAPP); bringing together international leaders of Parkinson’s platform trials

Stakeholders involved in the setup and running of Parkinson’s platform trials met in November for the second annual International PD-Platform Meeting. The result was the launch of GAPP with representatives from the UK, France, the US, Norway, and Australia. GAPP is facilitated by a collaboration…